India
Medical Technologies Sector Review
Definition and scale of sector
- Polymer/metal components,
- Electronics/electromechanical sub assemblies,
- Medical instrumentation,
- Pharmaceutical production, wholesaling
Why the sector was chosen in the West Midlands
- High rate of growth but from a low case.
- Full role played by the medical market place on regional industry is understated given the role played by industries that supply multiple markets e.g. polymers.
- Higher Education based investments demonstrate a potential for spin off activity. Opportunities for diversification. Major training region in Medical Schools and CE for the NHS.
Top of page 
Discovering new drugs - A Report from IBEF - December 2007
In the late 1990s when the life threatening Hepatitis B took an epidemic form all over India, a little known company from Hyderabad teamed up with a host of leading hospitals across the nation to develop a drug, which is today popularly known as Shanvac-B.
It happens to be the fi rst indigenously developed Hepatitis B vaccine in India, heralding the arrival of innovation in the pharmaceutical and biotechnology industry.
Source: India Brand Equity Foundation (IBEF)
FOR THE FULL REPORT PLEASE CLICK HERE
Biotech Boom - Gathering steam - A Report from IBEF - December 2007
India, which has earned a name worldwide as the most preferred destination for global Information Technology (IT) outsourcing and software services firms, is gradually making a mark in another high-tech sector – biotechnology. This sunrise sector, which has seen the entry of many new players both Indian and international, is poised to take the country to the big league with investments
flowing in from all corners. The country has traditionally done well in the pharmaceutical and drug industry. As an offshoot of the pharmaceutical industry, the biotechnology sector took shape over the last 10 years with many entrepreneurs making substantial investments in it.
According to Dr M.K. Bhan, Secretary, Department of Biotechnology, Government
of India, the industry – currently expanding at 37 per cent per annum – is growing phenomenally, and this can easily be sustained. It is projected to burgeon into a $5 billion sector by 2010.
Source: India Brand Equity Foundation (IBEF)
FOR THE FULL REPORT PLEASE CLICK HERE
Biotechnology Sector Report - July 2007
India is a priority emerging market for UK Trade & Investment. Recent developments in the sector in India indicate increasing business opportunities for the UK’s biotechnology sector.
Following the phenomenal success of its information technology industry, India is fast emerging as an important player in the biotechnology sector in the Asia–Pacific Region. The large pool of scientific talent available at a reasonable cost, a wealth of R & D Institutions, a rich and varied bio-diversity, a flourishing pharmaceutical industry, strong IT skills and an English speaking population has placed India favourably in the global market.
FOR THE FULL REPORT PLEASE CLICK HERE
Source: UK Trade and Investment
Top of page 
Pharmaceutical Sector Review - July 2007
Biotechnology & Pharmaceuticals are a priority sector. From 01/01/2005, a new TRIPS-compliant IPR regime as mandated by the WTO is in place. Following the approval of the Patents (3rd Amendment) Bill by the Indian Parliament on 23 March 2005, the Indian Pharmaceuticals sector now merits an active watching brief.
The Indian Pharmaceutical sector is highly fragmented with over 20,000 registered units. The leading 250 pharmaceutical companies control 70% of the market, with the market leader Glaxo SKB having only a 5.4 % market share (CY 2004). The top 10 companies cover around 31% of the pharma market. Because of Government price controls and the fragmented nature of the market, it is an extremely competitive industry which has evolved around the opportunities presented in the regulated environment
FOR THE FULL REPORT PLEASE CLICK HERE
Pharmaceutical - Overview from IBEF - July 2007
In 2007, the Indian pharmaceutical industry looks ahead at a colourful horizon, what with contract research and clinical trials businesses taking wing, and the new patent regime opening new avenues for players in the country.
Globally the Indian pharmaceutical industry ranks 4th in terms of volume (with an 8 per cent share in global sales) and 13th in terms of value (with a share of 1 per cent in global sales). Today, the sector today is in the front rank of India’s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology. A highly organised sector, the Indian pharmaceutical industry is estimated to be worth US$ 4.5 billion, growing at over 9 per cent annually.
FOR THE FULL REPORT PLEASE CLICK HERE
Source: India Brand Equity Foundation (IBEF)
Research and Development - Overview from IBEF - July 2007
India is fast emerging as the global research and development (R&D) hub of the world. In the past ten years the country has moved from a peripheral position in knowledge and technology sectors to being at the core of the continuous flow of people, ideas and technologies around the world. In 2006 alone, for example, 100 of the world's top R&D companies employed more than 15,000 scientists in India.
FOR THE FULL REPORT PLEASE CLICK HERE
Source: India Brand Equity Foundation (IBEF)
Top of page
Science and Technology - Overview from IBEF - July 2007
India is fast emerging as the global research and development (R&D) hub of the world. In the past ten years the country has moved from a peripheral position in knowledge and technology sectors to being at the core of the continuous flow of people, ideas and technologies around the world. In 2006 alone, for example, 100 of the world's top R&D companies employed more than 15,000 scientists in India.
FOR THE FULL REPORT PLEASE CLICK HERE
Source: India Brand Equity Foundation (IBEF)
Opportunity in India - June 2007
India is an obvious “potential” market for any UK company considering exports. But it is important that it is seen as a very sophisticated market. It has a middle class of 300 million people who want access to all the products common to the UK High Street. They may not yet have the purchasing power to buy at UK prices, but they do have the capability to enter into partnerships to produce locally at local prices.
This report highlights on the opportunities and expressed need in Indian Economy for all these trade clusters:
- Medical Technologies (biotech & pharmaceuticals; healthcare)
- Transport Technologies (aviation, automotive, infrastructure)
- Business Professional Services (education & training, insurance, tariffs)
- Tourism and Leisure (heritage & restoration, travel and tourism)
- Food and Drink
- Information Communication Technologies (telecom)
- Screen, Image and Sound (media)
The above highlights serve to illustrate the fact that India is ready to do business in almost every sector. It is a market, which is set to continuing growing for at least another 30 years as a result of its own demography.
Source: UK Trade and Investment
FOR THE FULL REPORT PLEASE CLICK HERE
Healthcare Sector - December 2006
Kolkata is emerging as a private healthcare destination. Many hospitals are expanding to meet demand from patients in Eastern India and neighbouring countries - Bangladesh, Nepal, Myanmar and Bhutan. The total investment by the private sector in hospital/healthcare infrastructure in Kolkata has been over £115 million in the last four to five years.
Currently, there are 12 private hospitals, under the banner of Association of Hospitals in Eastern India (AHEI). Between them, they offer general care and the following specializations: neurology, oncology, child & mother, cardiac, lifestyle diseases, and emergency & trauma care. UKTI has good relations with these hospitals, who all met the visiting Healthcare Export Promoter, David Hawkins, in November 2006.
Source: UK Trade and Investment (UKTI)
FOR THE FULL REPORT PLEASE CLICK HERE
Healthcare and Medical Sector Review - November 2006
The Indian healthcare & medical equipment sector holds good business opportunities for UK healthcare companies. According to The Economic Times Healthcare 2001-02 Report, India's healthcare industry grew at 13% per annum over the last decade and is currently growing at 17% annually. The report expects healthcare delivery will reach a size of Rs 1862 billion (£ 26.6 billion) by 2005-06.
The growth is being propelled by an increasingly affluent and more consumer-orientated middle class population of 100 million who are seeking and willing to pay for a higher standard of healthcare. The private sector is playing an increasingly important role in the provision of healthcare services. According to a theme paper on healthcare produced by the Confederation of Indian Industry (CII) the private sector attends to over 75% of medical complaints and accounts for 88% of total health expenditure.
FOR THE FULL REPORT PLEASE CLICK HERE
Source: UK Trade and Investment
Top of page | 
